Clinical trial Recruiting at 1 site Observational Ages 6 to 11

Profiling microbiome and metabolites in children with obstructive sleep apnea

Official title: Microbiome and Metabolomics Profiling in Children With Obstructive Sleep Apnoea

Run by Chinese University of Hong Kong · NCT06452992 · Data updated 2026-11-12

This study looks at the differences in gut bacteria and urine chemicals between children with obstructive sleep apnea and those without to see how these might be related to the condition.

Quick facts

Study typeObservational
Ages6 Years to 11 Years
SexAll
Enrollment130 (estimated)
SponsorChinese University of Hong Kong
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (Hong Kong)
StatusRecruiting
StartedJuly 1, 2023
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedOctober 21, 2026
Trial IDNCT06452992 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children aged 6-11 years diagnosed with obstructive sleep apnea.

Probably not a fit

Patients with previous upper airway surgery, genetic or syndromal diseases, or other specified conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the differences in microbiome composition and urine metabolomic profiles between children aged 6-11 with obstructive sleep apnea (OSA) and those without. By comparing nasal and stool samples, as well as urine metabolites, the study seeks to uncover potential pathological processes associated with OSA. The hypothesis is that children with OSA will exhibit distinct microbiome and metabolomic profiles compared to non-OSA controls, which may be linked to inflammatory responses. This research could provide insights into the underlying mechanisms of OSA and its related health impacts.

Why it matters

Potential benefit: If successful, this study could lead to a better understanding of the biological factors contributing to obstructive sleep apnea in children, potentially guiding future treatments.

How similar studies have gone: While the specific approach of combining microbiome and metabolomic profiling in OSA is relatively novel, previous studies have indicated potential links between microbiome changes and various health conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children aged 6-11 years old

Exclusion Criteria:

* Previous upper airway surgery, genetic or syndromal disease, congenital or acquired neuromuscular disease, suspected or confirmed congenital or acquired immunodeficiency, known metabolic syndrome, craniofacial abnormalities, structural or congenital heart disease, use of medications or therapy that could affect immunity such as systemic corticosteroids, chemotherapy, radiation therapy, intravenous immunoglobulins.

Where it's running

  • Prince of Wales Hospital
    Hong Kong, Hong Kong
    Recruiting

Study contacts

  • Principal investigator: Kate Ching Ching Chan, MD — Chinese University of Hong Kong
  • Study coordinator: Kate Ching Ching Chan, MD
  • Email: katechan@cuhk.edu.hk
  • Phone: 35053515

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.